XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.23.1

Fair value measurements (Tables) | 3 Months Ended
--- | ---
Apr. 01, 2023
Fair Value Disclosures [Abstract] |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table provides information for assets and liabilities measured at fair value on a recurring basis using Level 2 and Level 3 inputs:
| April 1, 2023 |  | December 31, 2022
| Total |  |  |  | Level 3 |  | Total |  |  |  | Level 3
Liabilities: |  |  |  |  |  |  |  |  |  |  |
Deferred Amount - Current(a) | $ | — |  |  |  |  | $ | — |  |  | $ | 117,615 |  |  |  |  | $ | 117,615 |
Deferred Amount - Long Term(a) | — |  |  |  |  | — |  |  | 79,269 |  |  |  |  | 79,269 |
CartiHeal contingent consideration- Sales Milestone(a) | — |  |  |  |  | — |  |  | 67,251 |  |  |  |  | 67,251 |
Bioness contingent consideration | 17,718 |  |  |  |  | 17,718 |  |  | 17,431 |  |  |  |  | 17,431 |
Total liabilities: | $ | 17,718 |  |  |  |  | $ | 17,718 |  |  | $ | 281,566 |  |  |  |  | $ | 281,566 |
(a)The Deferred Amount and contingent consideration attributable to CartiHeal have been reclassified to discontinued operations within the December 31, 2022 balance sheet. CartiHeal was fully deconsolidated during the first quarter of 2023. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details regarding the deconsolidation of CartiHeal.
Schedule of Fair Value Measurement Inputs and Valuation Techniques | A summary of unobservable Level 3 inputs utilized for the above liabilities are as follows:
| Valuation Technique |  | Unobservable inputs |  | Range
Bioness contingent consideration | Discounted cash flow |  | Payment discount rate |  | 6.4% - 6.8%
|  |  | Payment period |  | 2024 - 2025

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration